UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data shown on the profile page to:

http://www.ucl.ac.uk/finance/secure/research/post_award
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
First implantable device for hypoxia-mediated angiogenic induction.
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Journal Article
  • Authors:
    Hadjipanayi E, Cheema U, Mudera V, Deng D, Liu W, Brown RA
  • Publication date:
    10/08/2011
  • Pagination:
    217, 224
  • Journal:
    J Control Release
  • Volume:
    153
  • Issue:
    3
  • Country:
    Netherlands
  • PII:
    S0168-3659(11)00188-X
  • Language:
    eng
  • Keywords:
    Adult, Angiogenesis Inducing Agents, Animals, Cell Hypoxia, Cells, Cultured, Collagen Type I, Drug Delivery Systems, Endothelial Cells, Enzyme-Linked Immunosorbent Assay, Female, Fibroblasts, Humans, Hypoxia-Inducible Factor 1, alpha Subunit, Immunohistochemistry, Implants, Experimental, Male, Neovascularization, Physiologic, Rabbits, Vascular Endothelial Growth Factor A
Abstract
Delayed or inadequate vascularisation is one of the major factors leading to tissue infarction and poor graft survival. Current vascularisation strategies that rely on delivering single growth factors have proved ineffective or hard to control in practise. An alternative approach has been identified by this group that relies on stimulation of physiological angiogenic factor cascades by engineering local cell-hypoxia, within a nano-fibrillar collagen material. Here we report on a novel, practical and effective implantable device for delivering engineered angiogenic signalling, on demand. Human dermal fibroblast-seeded dense-collagen depots were pre-conditioned under physiological cell-generated hypoxia to up-regulate production of key angiogenic factors, including HIF1α and VEGF(165). The level of VEGF(165) protein retained within depots (indicating general angiogenic factor production) was directly correlated to the duration of pre-conditioning. Angiogenic factor delivery from pre-conditioned, non-viable depots rapidly induced an angiogenic response within endothelial cell-seeded constructs in vitro, while implanted acellular 3D constructs incorporating such angiogenic depots in their core were infiltrated with perfused vessels by 1 week in vivo, at which stage non-angiogenic implants were minimally perfused. Depot stability, tuneability of cell/matrix composition with long clinical experience of the collagen material, together with cost effectiveness, make this angiogenic therapy a promising addition to a clinician's tool kit for improving local tissue perfusion.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Authors
Inst of Orthopaedics & Musculosk Sci
Inst of Orthopaedics & Musculosk Sci
Inst of Orthopaedics & Musculosk Sci
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by